Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy

A 66-year-old woman with follicular lymphoma on lenalidomide and rituximab presented with chest pain. High-sensitivity troponin T peaked at 7,566 ng/l. Cardiac biopsy revealed extensive inflammation consistent with medication-induced myocarditis. Lenalidomide was stopped with improvement in troponin...

Full description

Bibliographic Details
Main Authors: Robin Jacob, MD, Paolo Strati, MD, Nicolas Palaskas, MD, Juan C. Lopez-Mattei, MD, Konstantinos Marmagkiolis, MD, L. Maximilian Buja, MD, Anita Deswal, MD, Cezar Iliescu, MD
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:JACC: Case Reports
Subjects:
cardio-oncology
cardiotoxicity
follicular lymphoma
lenalidomide
myocarditis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084920309098

Internet

http://www.sciencedirect.com/science/article/pii/S2666084920309098

Similar Items